AI news impact · China A-shares
Walvax Biotechnology Co., Ltd. Class A (300142) news impact
On 2026-10-21 Wave Radar's AI rated the news on Walvax Biotechnology Co., Ltd. Class A as neutral (impact score 0%).
Walvax Biotechnology's ticker appeared solely at the end of statistical tables tracking multi-day margin balance declines across the ChiNext market.
- Direction
- Neutral
- Impact score
- 0%
- Confidence
- 55%
- Headlines read
- 5
- Date
- 2026-10-21
AI assessment
Passively listed in routine market margin reduction tables with no fundamental catalysts, exerting neutral impact on stock trajectory.
Sector impact
No direct industrial impact on the vaccine or biopharmaceutical sectors.
Headlines the AI read
- 杠杆资金连续八日减仓创业板股 AkShare/证券时报网 · 2026-10-21
- 创业板公司融资余额六连降 其间累计减少272.28亿元 AkShare/证券时报网 · 2026-10-19
- 创业板公司融资余额五连降 其间累计减少241.71亿元 AkShare/证券时报网 · 2026-10-16
- 创业板公司融资余额四连降 其间累计减少123.17亿元 AkShare/证券时报网 · 2026-10-15
- 创业板公司融资余额三连降 其间累计减少97.30亿元 AkShare/证券时报网 · 2026-10-14
Rating history
One rating per trading day the stock was covered.
More on Walvax Biotechnology Co., Ltd. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.